tiprankstipranks
Trending News
More News >
Teva Pharmaceutical (DE:TEV)
FRANKFURT:TEV
Germany Market

Teva Pharmaceutical (TEV) Income Statement

Compare
36 Followers

Teva Pharmaceutical Income Statement

Last quarter (Q4 2025), Teva Pharmaceutical's total revenue was $4.71B, an increase of 11.40% from the same quarter last year. In Q4, Teva Pharmaceutical's net income was $480.00M. See Teva Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 17.26B$ 16.54B$ 15.85B$ 14.93B$ 15.88B
Gross Profit
$ 8.94B$ 8.06B$ 7.64B$ 6.97B$ 7.59B
Operating Expenses
$ 6.78B$ 8.37B$ 7.21B$ 9.17B$ 5.88B
Depreciation and Amortization
$ 1.00B$ 1.06B$ 1.15B$ 1.31B$ 1.33B
EBITDA
$ 3.14B$ 4.43B$ 1.56B$ -925.00M$ 4.41B
Operating Income
$ 2.16B$ -303.00M$ 433.00M$ -2.20B$ 1.72B
Other Income/Expenses
$ -919.00M$ -980.00M$ -1.05B$ -945.00M$ -1.05B
Pretax Income
$ 1.24B$ -1.28B$ -622.00M$ -3.14B$ 667.00M
Net Income
$ 1.41B$ -1.64B$ -559.00M$ -2.45B$ 417.00M
Per Share Metrics
Basic EPS
$ 1.23$ -1.45$ -0.50$ -2.20$ 0.38
Diluted EPS
$ 1.20$ -1.45$ -0.50$ -2.20$ 0.38
Weighted Average Shares Outstanding
1.15B 1.13B 1.12B 1.11B 1.10B
Weighted Average Shares Outstanding (Diluted)
1.17B 1.13B 1.12B 1.11B 1.11B
Currency in USD

Teva Pharmaceutical Earnings and Revenue History